XBI SPDR® S&P Biotech ETF Forecast, Technical & Fundamental Analysis
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U... Show more
XBI's RSI Indicator is sitting in overbought zone for 14 days
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 20 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XBI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
XBI broke above its upper Bollinger Band on September 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for XBI just turned positive on September 18, 2025. Looking at past instances where XBI's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XBI advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 224 cases where XBI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Advertisement
General Information
Category Health
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GCV | 4.32 | 0.10 | +2.37% |
| Gabelli Convertible and Income Securities Fund (The) | |||
| BBH | 179.18 | 2.53 | +1.43% |
| VanEck Biotech ETF | |||
| GPIQ | 52.93 | 0.60 | +1.15% |
| Goldman Sachs Nasdaq-100 Premium Inc ETF | |||
| EAOK | 27.65 | 0.10 | +0.38% |
| iShares ESG Aware 30/70 Cnsrv Allc ETF | |||
| HBMBF | 237.00 | N/A | N/A |
| HBM Bioventures AG | |||
XBI and ETFs
Correlation & Price change
A.I.dvisor indicates that over the last year, XBI has been closely correlated with IBBQ. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if XBI jumps, then IBBQ could also see price increases.
| Ticker / NAME | Correlation To XBI | 1D Price Change % | ||
|---|---|---|---|---|
| XBI | 100% | +2.20% | ||
| IBBQ - XBI | 93% Closely correlated | +1.33% | ||
| SBIO - XBI | 93% Closely correlated | +2.54% | ||
| IBB - XBI | 92% Closely correlated | +1.49% | ||
| BBC - XBI | 91% Closely correlated | +4.34% | ||
| GNOM - XBI | 91% Closely correlated | +4.28% | ||
More | ||||